MedTrace Logo

Eye-Tracking Rapid Attention Computation

NCT00743821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426

Last updated 2014-05-07

No results posted yet for this study

Summary

The purpose of this study is to validate and refine a diagnostic device that can detect attention and memory deficits that result from mild traumatic brain injury (mTBI).

Conditions

  • Post Concussive Syndrome, Chronic

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Brain Trauma Foundation

    lead OTHER

Principal Investigators

  • Jamshid Ghajar, M.D., Ph.D. · Brain Trauma Foundation

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743821 on ClinicalTrials.gov